Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 449 followers

Latest posts

Last updated 3 minutes ago

Draft guideline on clinical investigation of medicinal products for the treatment of migraine and cluster headache - Revision 2

about 3 hours ago

Draft guideline on clinical investigation of medicinal products for the treatment of...

Clinical investigation of medicinal products for treatment of migraine - Scientific guideline

about 3 hours ago

Clinical investigation of medicinal products for treatment of migraine - Scientific guideline

PSUSA/00000405/202601

about 20 hours ago

PSUSA/00000405/202601

Human medicines European public assessment report (EPAR): Amvuttra, vutrisiran, Date of authorisation: 15/09/2022, Revision: 6, Status: Authorised

about 20 hours ago

Human medicines European public assessment report (EPAR): Amvuttra, vutrisiran, Date of authorisation...

Orphan medical devices regular process: 2027 timetable

about 21 hours ago

Orphan medical devices regular process: 2027 timetable

Expert panel support for orphan medical devices

about 21 hours ago

Expert panel support for orphan medical devices

Advice to medical device manufacturers - 2027 Timetable

about 21 hours ago

Advice to medical device manufacturers - 2027 Timetable

Human medicines European public assessment report (EPAR): Perjeta, pertuzumab, Date of authorisation: 04/03/2013, Revision: 27, Status: Authorised

about 21 hours ago

Human medicines European public assessment report (EPAR): Perjeta, pertuzumab, Date of authorisation...

Human medicines European public assessment report (EPAR): Colchicine Agepha Pharma, colchicine, Date of authorisation: 24/07/2026, Status: Authorised

about 21 hours ago

Human medicines European public assessment report (EPAR): Colchicine Agepha Pharma, colchicine, Date...

Human medicines European public assessment report (EPAR): Zercepac, trastuzumab, Date of authorisation: 27/07/2020, Revision: 16, Status: Authorised

about 21 hours ago

Human medicines European public assessment report (EPAR): Zercepac, trastuzumab, Date of authorisation...